Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity.

View resource
HDx

Theranova versus FX80: The impact on anemia management in hemodialysis.

View resource
HDx

Effect of Hemodialysis with Medium Cut-Off versus High-Flux Membranes on Endothelial Function of Patients with Chronic Kidney Disease

View resource
HDx

Latest Trends in Hemodiafiltration.

View resource
HDx

Most recently developed polyester polymer alloy dialyzer: A new medium cut-off membrane?.

View resource
HDx

Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring.

View resource
HDx

Intradialytic Tolerance and Recovery Time in Different High-Efficiency Hemodialysis Modalities.

View resource
HDx

The Budgetary Impact of Introducing HDx therapy enabled by Theranove Dialyzer compared to High Flux Hemodialysis in private sector in the Kingdom of Saudia Arabia

View resource
HDx

Endotoxin Retentive Performance of the Fresenius FX CorAL Dialyzer.

View resource
HDx

A Budget Impact Model (BIM) for Expanded Haemodialysis (HDx) vs. High-Flux Haemodialysis (HF-HD) in Two Major Public Health Sectors, Kingdom of Saudi Arabia (KSA)

View resource
HDx

The optimized anticoagulation strategy in prolonged hemodialysis.

View resource
HDx

Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration

View resource